²ÝÁñÊÓƵ

ONG-GO, Arlinking K.

ONG-GO, Arlinking K.

Assistant Professor Arlinking Ong-Go is an internal medicine specialist with over 12 years of experience in gastroenterology and hepatology. She is board-certified in internal medicine and gastroenterology and is particularly interestedÌýin liver diseases. Dr. Ong-Go is actively involved in research and serves as a mentor to residents and fellows. She is a member of several professional organizations, including the Philippine Society of Gastroenterology, one of the current executive board members, and the Hepatology Society of the Philippines, where she was past president.

Updates

UST recognizes research achievements of faculty

UST recognizes research achievements of faculty

A total of 121 faculty members were recognized in the…

Asst. Prof. Arlinking K. Ong-Go, MD, FPCP, FPSG, FPSDE

Department of Medicine | Faculty of Medicine and Surgery

akong-go@ust.edu.ph

Academic Qualifications

Research Highlights

Research Interests

Academic Qualifications

Degrees

  • Doctor of Medicine, University of the East Ramon Magsaysay Memorial Medical Center, 1997-2001Ìý

Eligibility

  • Professional Regulation Commission Physician Licensure Examination

Postgraduate TrainingsÌýÌý

  • Interventional Hepatology, Chang Gung Memorial Hospital, Taiwan, 2011
  • Clinical Hepatology, Prince of Wales Hospital The Chinese University of Hong Kong, 2010-2011
  • Fellowship in Gastroenterology, University of Santo Tomas Hospital – Manila, Philippines, 2007-2009
  • Residency in Internal Medicine, Chief Fellow, Metropolitan Medical Center, 2004-2006Ìý

Research Highlights

  • Dr Ong-Go has received numerous recognition and awards throughout her career, including the Presidential Award from the Asia-Pacific Association for the Study of the Liver in 2011 for her work on the treatment options for Lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by Adefovir. She was alsoÌýawarded the Young Investigator Award from the Asia-Pacific Digestive Week in 2008. Dr Ong-Go has published extensively in several reputable medical journals, including the Journal of Hepatology and Lancet Gastroenterology and Hepatology

Research Interests

  • Gastroenterology
  • Hepatology

Courses Handled

Major Recognitions

Professional Activities

Courses Handled

  • Medicine 1 – Physical Diagnosis (2ndÌýyear Medical Students)
  • Medicine 2 (3rd year Medical Students)Ìý

Major Recognitions

  • Clinician-Scientist Training Fellowship Awardee, Asia Pacific Association of Gastroenterology/Journal of Gastroenterology and Hepatology Foundation, 2010Ìý
  • Presidential Award, Asia-Pacific Association for the Study of the Liver, Bangkok, Thailand, 2011Ìý
  • Young Investigator Award, Asia-Pacific Digestive Week, New Delhi, India, 2008Ìý
  • 3rd Place,Ìý Oral Paper Presentation (Retrospective), PSG-PSDE-HSP Joint Annual Convention, 2008
  • Best Poster in Free Communication Poster Session (Meta-Analysis and Descriptive Category), 37th Annual PCP Convention

Professional Activities

Academic AppointmentÌý

  • Assistant Professor 2, Department of Medicine, UST Faculty of Medicine & SurgeryÌý

ÌýAdministrative Appointments/PositionsÌý

  • Treasurer, Philippine Society of Gastroenterology, Research Coordinator Department of Internal Medicine Metropolitan Medical Center
  • Research Coordinator, Section of Gastroenterology Metropolitan Medical Center

Past Positions

  • President, Hepatology Society of the Philippines, 2019-2020

Professional Affiliations

  • Fellow, Philippine College of Physicians
  • Fellow, Philippine Society of Gastroenterology
  • Fellow, Philippine Society of Digestive Endoscopy

Hospital AffiliationsÌý

  • Metropolitan Medical Center Our Lady of Lourdes Hospital

Selected Publications

Selected Publications

  • Treatment Options for Lamivudine-Resistant Chronic Hepatitis B Patients With Suboptimal Virological Suppression By Adefovirak. Ong, VWS Wong, GLY Wong, HLY ChanInstitute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. (published Alimentary Pharma Therapeutics 2011 Oct;34(8):972-81. doi: 10.1111/j.1365-2036.2011.04833.x. Epub 2011 Aug 24)
  • The Effect of Caffeine and Alcohol Consumption on Liver Fibrosis – A Study of 1045 Hepatitis B Patients Using Transient Elastographyak. Ong, VWS Wong, GLY Wong, HLY Chan Institute of Digestive Disease and Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, SAR, China. (published Liver International Vol 31 pp1047- 53 Aug 2011)
  • Management of Patients with Liver Derangement during the Covid-19 Pandemic Asia-Pacific Position Statement. GLH Wong…AK Ong-Go, HLY Chan. Lancet Gastroenterol Hepatol. 2020 Aug;5(8):776-787.doi:10.1016/S2468-1253(20)30190-4.Epub 2020 Jun 23.
  • Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. SC Ng…. AK Ong-Go.. JYSung. Am J Gastroenterol. 2019 Jan; 114(1):107-115. doi:10.1038/s41395-018-0233-2.2018
  • Update to the Consensus Statement on the Treatment of Hepatitis C. AK Ong-Go et al. PJIM. Vol56 Num 1. Oct-Dec 2018. P 196-209.